Boston Scientific Property, Plant, and Equipment 2010-2024 | BSX
Boston Scientific property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
- Boston Scientific property, plant, and equipment for the quarter ending June 30, 2024 was $2.951B, a 16.46% increase year-over-year.
- Boston Scientific property, plant, and equipment for 2023 was $2.859B, a 16.88% increase from 2022.
- Boston Scientific property, plant, and equipment for 2022 was $2.446B, a 8.61% increase from 2021.
- Boston Scientific property, plant, and equipment for 2021 was $2.252B, a 8.06% increase from 2020.
| Boston Scientific Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2023 | $2,859 |
| 2022 | $2,446 |
| 2021 | $2,252 |
| 2020 | $2,084 |
| 2019 | $2,079 |
| 2018 | $1,782 |
| 2017 | $1,697 |
| 2016 | $1,630 |
| 2015 | $1,490 |
| 2014 | $1,507 |
| 2013 | $1,546 |
| 2012 | $1,564 |
| 2011 | $1,670 |
| 2010 | $1,697 |
| 2009 | $1,722 |
| Boston Scientific Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024-06-30 | $2,951 |
| 2024-03-31 | $2,897 |
| 2023-12-31 | $2,859 |
| 2023-09-30 | $2,635 |
| 2023-06-30 | $2,534 |
| 2023-03-31 | $2,478 |
| 2022-12-31 | $2,446 |
| 2022-09-30 | $2,273 |
| 2022-06-30 | $2,246 |
| 2022-03-31 | $2,265 |
| 2021-12-31 | $2,252 |
| 2021-09-30 | $2,109 |
| 2021-06-30 | $2,082 |
| 2021-03-31 | $2,053 |
| 2020-12-31 | $2,084 |
| 2020-09-30 | $2,064 |
| 2020-06-30 | $2,079 |
| 2020-03-31 | $2,098 |
| 2019-12-31 | $2,079 |
| 2019-09-30 | $1,942 |
| 2019-06-30 | $1,820 |
| 2019-03-31 | $1,782 |
| 2018-12-31 | $1,782 |
| 2018-09-30 | $1,730 |
| 2018-06-30 | $1,715 |
| 2018-03-31 | $1,700 |
| 2017-12-31 | $1,697 |
| 2017-09-30 | $1,678 |
| 2017-06-30 | $1,651 |
| 2017-03-31 | $1,652 |
| 2016-12-31 | $1,630 |
| 2016-09-30 | $1,500 |
| 2016-06-30 | $1,487 |
| 2016-03-31 | $1,464 |
| 2015-12-31 | $1,490 |
| 2015-09-30 | $1,479 |
| 2015-06-30 | $1,451 |
| 2015-03-31 | $1,458 |
| 2014-12-31 | $1,507 |
| 2014-09-30 | $1,522 |
| 2014-06-30 | $1,534 |
| 2014-03-31 | $1,539 |
| 2013-12-31 | $1,546 |
| 2013-09-30 | $1,530 |
| 2013-06-30 | $1,524 |
| 2013-03-31 | $1,537 |
| 2012-12-31 | $1,564 |
| 2012-09-30 | $1,624 |
| 2012-06-30 | $1,632 |
| 2012-03-31 | $1,669 |
| 2011-12-31 | $1,670 |
| 2011-09-30 | $1,684 |
| 2011-06-30 | $1,702 |
| 2011-03-31 | $1,708 |
| 2010-12-31 | $1,697 |
| 2010-09-30 | $1,712 |
| 2010-06-30 | $1,708 |
| 2010-03-31 | $1,712 |
| 2009-12-31 | $1,722 |
| 2009-09-30 | $1,731 |
| 2009-06-30 | $1,719 |
| 2009-03-31 | $1,708 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $121.595B | $14.240B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $199.879B | 25.82 |
| Stryker (SYK) | United States | $137.705B | 32.18 |
| Medtronic (MDT) | Ireland | $113.026B | 16.82 |
| EssilorLuxottica (ESLOY) | France | $104.378B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.118B | 35.17 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.437B | 0.00 |
| ResMed (RMD) | United States | $34.974B | 30.79 |
| Koninklijke Philips (PHG) | Netherlands | $29.016B | 22.05 |
| Terumo (TRUMY) | Japan | $27.876B | 39.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.644B | 13.63 |
| Baxter (BAX) | United States | $20.086B | 13.62 |
| Insulet (PODD) | United States | $16.555B | 69.65 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.426B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.489B | 31.44 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.672B | 32.44 |
| Lantheus Holdings (LNTH) | United States | $7.508B | 18.02 |
| ICU Medical (ICUI) | United States | $4.304B | 41.08 |
| TG Therapeutics (TGTX) | United States | $3.909B | 41.39 |
| Haemonetics (HAE) | United States | $3.870B | 19.14 |
| Perrigo (PRGO) | Ireland | $3.841B | 12.14 |
| GN Store Nord (GNNDY) | Denmark | $3.758B | 22.64 |
| Neogen (NEOG) | United States | $3.736B | 39.18 |
| Prestige Consumer Healthcare (PBH) | United States | $3.644B | 18.16 |
| Envista Holdings (NVST) | United States | $3.298B | 17.60 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.591B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.311B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.171B | 36.43 |
| LeMaitre Vascular (LMAT) | United States | $1.996B | 53.20 |
| AdaptHealth (AHCO) | United States | $1.524B | 11.00 |
| InMode (INMD) | Israel | $1.466B | 9.34 |
| Warby Parker (WRBY) | United States | $1.466B | 0.00 |
| AtriCure (ATRC) | United States | $1.363B | 0.00 |
| Owens & Minor (OMI) | United States | $1.219B | 9.41 |
| Verano Holdings (VRNOF) | United States | $1.114B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.094B | 0.00 |
| Evolus (EOLS) | United States | $1.023B | 0.00 |
| PetIQ (PETQ) | United States | $0.920B | 23.32 |
| Phibro Animal Health (PAHC) | United States | $0.897B | 18.61 |
| National Vision Holdings (EYE) | United States | $0.864B | 27.48 |
| Cresco Labs (CRLBF) | United States | $0.801B | 0.00 |
| Surmodics (SRDX) | United States | $0.561B | 119.09 |
| Quanterix (QTRX) | United States | $0.543B | 0.00 |
| ZimVie (ZIMV) | United States | $0.454B | 42.23 |
| VAREX IMAGING (VREX) | United States | $0.451B | 13.62 |
| Valneva SE (VALN) | France | $0.422B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.406B | 0.00 |
| Jin Medical (ZJYL) | China | $0.397B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.333B | 0.00 |
| Cerus (CERS) | United States | $0.330B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.321B | 8.29 |
| Aurora Cannabis (ACB) | Canada | $0.320B | 0.00 |
| Biote (BTMD) | United States | $0.319B | 14.70 |
| Viemed Healthcare (VMD) | United States | $0.287B | 30.79 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| Zynex (ZYXI) | United States | $0.260B | 45.44 |
| Utah Medical Products (UTMD) | United States | $0.234B | 15.52 |
| Ayr Wellness (AYRWF) | United States | $0.232B | 0.00 |
| Omeros (OMER) | United States | $0.228B | 0.00 |
| MacroGenics (MGNX) | United States | $0.207B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.170B | 70.33 |
| Capricor Therapeutics (CAPR) | United States | $0.167B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 20.62 |
| Brainsway (BWAY) | Israel | $0.140B | 168.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.125B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.124B | 0.00 |
| Veru (VERU) | United States | $0.113B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.099B | 24.20 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.075B | 0.00 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.056B | 3.63 |
| Exagen (XGN) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.036B | 0.00 |
| Bright Green (BGXX) | United States | $0.028B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Agape ATP (ATPC) | $0.008B | 0.00 | |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.47 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |